The NYSE welcomes Hims & Hers to celebrate its 5th anniversary of listing! $HIMS
@wearehims | @wearehers xitter.cf/i/broadcasts/1jGXgBBRW…
Tim Doyle retweeted
Today, we’re on the fast track to becoming the leading global consumer health platform: we’ve agreed to acquire Eucalyptus, an international innovator in digital health.
We’ve spent several years investing in our international footprint because we know that the status quo in healthcare across the world still doesn’t put the individual at the center. When I met @_Timdoyle many years ago, I knew immediately that we shared a similar perspective on how to change the status quo.
Helping people feel great means tackling multiple conditions and recognizing that one size doesn’t fit all. It requires a diversified platform that can meet almost anyone where they are with care that is built for them. It’s what makes Tim and his team leaders outside the US, and it’s why we’ve made the decision to welcome them to Hims & Hers after closing. Their dedication to consumers has resulted in an incredible business with an ARR north of $450 million USD that delivered triple-digit year-over-year ARR growth every quarter last year.
Together, we’re going to push the industry to put people at the center of healthcare and help more people experience care that feels like a luxury without costing like one.
I have always known the value of what we’re building for customers at Hims & Hers isn’t restricted to borders. That’s even more true today.
Read more here, including important footnotes and disclaimers: investors.hims.com/news/news…
Tim Doyle retweeted
Grit isn’t showing up in the office 9-9-6 when the VC dollars are flowing and ACV doubles every week; it’s pushing through and showing up when everything is falling apart but you still believe
Tim Doyle retweeted
Today, we’re launching Parsed. We are incredibly lucky to live in a world where we stand on the shoulders of giants, first in science and now in AI. Our heroes have gotten us to this point, where we have brilliant general intelligence in our pocket. But this is a local minima. We now have an ecosystem of burgeoning tasks where each requires a different kind of intelligence, a different context, a whole host of implicit assumptions and latent knowledge and domain expertise that is very difficult to cram into a system prompt.
The big labs want you renting their $50k/month amnesiac interns that forget everything between conversations. Generic behemoths that get quantised, versioned and deprecated behind the scenes, where the only element of control you have is your messy monolithic user prompt. We want people who need their own intelligence to be able to not only access it, but also control it. And whilst the big general models are unbelievably good chatbots and coding agents and purveyors of the world, specialisation of intelligence is required. Clinical scribes, marketing compliance agents, legal red-lining models, insurance policy recommenders, the list goes on.
And so that’s what Parsed does: deploy your own frontier model that actually learns. We eval your specific task, build a custom evaluation harness, optimise a model just for you, and host it with continual learning. We bake all the context and knowledge of your task into the model itself, from your engineers to your domain experts to customer feedback, all in a tight SFT → RL loop, with useful interpretability made possible by the open-source ecosystem we build on top of. No more 2000-word prompts with seventeen "IMPORTANT: NEVER DO X" clauses. Your model gets better at YOUR job every single day; the amnesiac pseudo-gods have had their run. Your model, your data, your moat. Let's build 🫡
Tim Doyle retweeted
i think about this chart a lot.
it's a great reminder of what product design is about.
Tim Doyle retweeted
"The skill is staying alive long enough to expose yourself to luck — and then executing in a world-class when it hits."
— @_Timdoyle , CEO & Co-Founder, Eucalyptus
New episode of Scaling Up just dropped — and this one’s a clinic. 😉
open.spotify.com/episode/6iw…
Tim Doyle retweeted
Incredible post on ghibli images and Art
by Scott Alexander
“We gripe about how LLMs are destroying wonder, never thinking about how we’re speaking to an alien intelligence made by etching strange sigils on a tiny glass wafer on a mountainous jungle island off the coast of China, then converting every book ever written into electricity and blasting them through the sigils at near-light-speed. It’s all amazing, and we’re bored to death of all of it.”
Tim Doyle retweeted

Noah Smith 🐇🇺🇸🇺🇦🇹🇼@Noahpinion20 Jan 2025
United States
United StatesConnected via United States Android AppAccount-level information, not a live location or per-post device.
Why does anyone watch Lex when Dwarkesh exists?
Tim Doyle retweeted
Tirzepatide keeps weight off for 172 weeks (over 3 years).
These aren’t short term bandaids. They are long term / chronic therapies for obesity.
investor.lilly.com/news-rele…
Tim Doyle retweeted
Lot of chatter around the decline of Nike being because of "performance marketing"
Tim Doyle retweeted
only when you’re personally involved with any piece of “news” do you realize just how off most hot takes really are, and just how much nuance, in aggregate, changes everything.
Tim Doyle retweeted
GLP1s are inevitable. Delaying coverage can be the single largest accelerant of health inequity in our lifetime and increasing it the most powerful tool to bridge the gap.
ro.co/weight-loss/glp1s-inev…
Tim Doyle retweeted
Back in 2016 I made the case that the problematic impact of fake news was ultimately a function of who delivered it, and that to focus on social media was a red herring. Seems pertinent.
stratechery.com/2016/fake-ne…
Tim Doyle retweeted
New @NEJM
A GLP-1 drug (semaglutide) led to lack of need for insulin in 7 of 10 people with recent onset Type 1 (autoimmune) diabetes, and the other 3 of 10 had eliminated need for insulin w/ meals
nejm.org/doi/full/10.1056/NE…
Tim Doyle retweeted
Only 3 days to go!
Join me for this all-access and candid fireside conversation with two of the best founders in @_Timdoyle and Rory on the realities of scaling "successful" startups.
Tickets are quickly selling out, get yours today 👇
trybooking.com/CIXTQ
Tim Doyle retweeted
New series - Provocations & round tables ✨
Ep #120 is now live!
- Founder evolution as business scales
- Campaign that surprised Tim the most
- What makes someone the best?
- Key learning for Alex and Tim in next 6 months
- Thinking in probabilities
curiositycenter.xyz/120-timd…
Tim Doyle retweeted
We’ve got @_Timdoyle coming on the pod this week 🌶️
What should we ask him?
Tim Doyle retweeted
The twitter files feels like the perfect analogy for Elon's tenure as owner: desperate to create something bigger; something meaningful; something cool. Not really working.
Tim Doyle retweeted
Reposting this, which I wrote in April 2020, as it becomes more and more relevant today.
"There is a cost to being too sad. You achieve less and take more time."
medium.com/p/89ad31cfb597




























